Publication:
Application of multiple stepwise spinning disk processing for the synthesis of poly(methyl acrylates) coated chitosan-diclofenac sodium nanoparticles for colonic drug delivery

dc.contributor.authorKampanart Huanbuttaen_US
dc.contributor.authorPornsak Sriamornsaken_US
dc.contributor.authorManee Luangtana-Ananen_US
dc.contributor.authorSontaya Limmatvapiraten_US
dc.contributor.authorSatit Puttipipatkhachornen_US
dc.contributor.authorLee Yong Limen_US
dc.contributor.authorKatsuhide Teradaen_US
dc.contributor.authorJurairat Nunthaniden_US
dc.contributor.otherSilpakorn Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Western Australia Faculty of Medicine and Dentistryen_US
dc.contributor.otherToho Universityen_US
dc.date.accessioned2018-10-19T05:42:59Z
dc.date.available2018-10-19T05:42:59Z
dc.date.issued2013-09-27en_US
dc.description.abstractThe production of pharmaceutical nanoparticles by the spinning disk processing (SDP) technique has advantages in terms of its scalability and its capacity to produce readily tunable nanoparticles of narrow size distribution. In this study, we successfully developed a novel multiple stepwise SDP technique to develop aggregates of uniformly sized poly(methyl acrylates)-coated chitosan-diclofenac sodium nanocores (CS-PMA NPs) for colonic drug delivery. The processing conditions were optimized using the Box-Behnken design. SEM and TEM micrographs showed the optimized system to consist of 10 μm-sized agglomerates of CS-PMA NPs, the latter measuring 10 nm in diameter. High drug entrapment of 88% was attained. Potential colon-targeted drug release from the CS-PMA NPs was demonstrated, with retardation of drug release in simulated gastrointestinal fluids and over 90% of the drug load released into simulated colonic fluid within 8 h. Drug uptake from CS-PMA NPs into Caco-2 cells was threefold higher than that from a control drug solution, with no apparent cytotoxicity observed at the NP doses administered. The collective data suggest that the SDP is a robust manufacturing method that can potentially be used to scale up the production of composite nanoparticulate colon-targeted drug delivery systems. © 2013 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationEuropean Journal of Pharmaceutical Sciences. Vol.50, No.3-4 (2013), 303-311en_US
dc.identifier.doi10.1016/j.ejps.2013.07.010en_US
dc.identifier.issn18790720en_US
dc.identifier.issn09280987en_US
dc.identifier.other2-s2.0-84884515405en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32731
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884515405&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleApplication of multiple stepwise spinning disk processing for the synthesis of poly(methyl acrylates) coated chitosan-diclofenac sodium nanoparticles for colonic drug deliveryen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884515405&origin=inwarden_US

Files

Collections